Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients.
In view of the evidence for the role of the central cholinergic pathways in memory and preliminary studies suggesting alteration of neurotransmitters after severe head injury, we completed a double-blind, placebo-controlled study of combined oral physostigmine and lecithin. Sixteen survivors of moderate to severe closed head injury who had unequivocal memory deficit were studied during the course of inpatient rehabilitation. Although the results generally indicated no difference in the effects of the physostigmine-lecithin combination as compared to lecithin alone, sustained attention on the continuous performance test was more efficient under physostigmine than placebo when the drug condition occurred first in the crossover design. Further investigation of neurotransmitter manipulation is warranted in patients with traumatic brain injury.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001288:Attention / Q000187:drug effects*; D001930:Brain Injuries / Q000523:psychology*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects*; D010713:Phosphatidylcholines / Q000008:administration & dosage / Q000627:therapeutic use*; D010830:Physostigmine / Q000008:administration & dosage / Q000627:therapeutic use*
D010713:Phosphatidylcholines; D010830:Physostigmine